PENN TWP — The Hunter Family of Companies recently promoted Nancy Mycka to executive vice president of public relations.

In her new role, she will develop the company's public relations division. She also will revive the company's newsletter starting in 2014 to be a quarterly electronic format.

Mycka will continue to oversee the company's safety efforts and will consult on employee benefits and insurance.

Mycka, one of four third-generation family owners of Hunter, has been with the company for more than 20 years. She was executive vice president of human resources.

Hunter, with its corporate headquarters at 480 Pittsburgh Road, has 20 locations in four states and employs nearly 800.

CRANBERRY TWP — Eric Susany is the new bank manager for the S & T Bank office in the township.Susany of Glenshaw previously was a loan officer and a financial center manager.He has a bachelor of science in business degree from the University of Pittsburgh.S & T Bank is headquartered in Indiana, Pa.

NEW YORK — Macy's and Martha Stewart Living Omnimedia say they have settled a breach-of-contract lawsuit involving J.C. Penney.But Macy's said the settlement does not impact its lawsuit against J.C. Penney, which is still ongoing.Macy's and Martha Stewart Living Omnimedia said their settlement terms are confidential and not material to their businesses. Both companies said they look forward to “a continued, successful partnership together.”

SALEM, Ore. — A new study has found that people enrolled recently in Medicaid went to the emergency room 40 percent more frequently than others, often seeking help for conditions that could be treated less expensively in a doctor's office or an urgent care clinic.The research, published by the journal Science, comes as millions of Americans gain health insurance under the federal health care law, many of them through Medicaid.

WASHINGTON — The Food and Drug Administration approved 27 first-of-a-kind drugs in 2013, down from 39 new medications in 2012, which was a 15-year high.Despite the decline, FDA officials say the tally of innovative medications approved last year is in line with the historical trend.FDA drug approvals are watched closely by analysts as both a barometer of industry innovation and the federal government's efficiency in reviewing new therapies.